ARTICLE | Clinical News

Maestro Rechargeable regulatory update

January 19, 2015 8:00 AM UTC

FDA approved EnteroMedics’ VBLOC vagal blocking therapy on the Maestro RC System to treat obesity in adults with a BMI of 40-45 kg/m 2 or with a BMI of 35-39.9 kg/m 2 with a related health condition. ...